Umar Nasir, MD
Sleep Medicine · Reno, NVNPI 1972845709
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,302 of the $6,089 with a category attached, or 70.6%. Inspire Medical Systems, Inc. accounts for 83.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $3,444 and has fallen 76.9% since, to $796 in 2025.
Across 95 payments — averaging $64.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$5K
- Jazz Pharmaceuticals Inc.$331
- Fisher & Paykel Healthcare Inc$282
- Novo Nordisk$139
- Harmony Biosciences LLC$86
- Avadel CNS Pharmaceuticals, LLC$52
- plus $142 from 5 others
What the payments were for
- Travel & lodging$1,69728%
- Food & beverage$4,30271%
- Education$901%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 58 | $5,057 |
| Jazz Pharmaceuticals Inc. | 7 | $331 |
| Fisher & Paykel Healthcare Inc | 14 | $282 |
| Novo Nordisk | 4 | $139 |
| Harmony Biosciences LLC | 4 | $86 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $52 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Philips North America LLC | 1 | $39 |
| 3b Medical, Inc. | 1 | $19 |
| ZOLL Respicardia, Inc. | 1 | $17 |
| Resmed Corp | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire Upper Airway Stimulation System$3,223
- Inspire$673
- Wegovy$125
- XYWAV$125
How this compares
Too few sleep medicine providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 30 | $354 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 18 | $269 |
| Trazodone Hcl | 30 | $203 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Reno
- Brandon FloresReno$5K
- Kimberly YeagerReno$4K
- Francis Paul BattungReno$2K
- William TorchReno$297
- John AndrewsReno$199
- Michael JacksonReno$24
- Tara RachakondaLas Vegas$6K
- Clifford MolinLas Vegas$4K
- Alexander BlatyNorth Las Vegas$2K
- Mohamed ShamiyaLas Vegas$960
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.